clobazam
Generic: clobazam
Labeler: northstar rxllcDrug Facts
Product Profile
Brand Name
clobazam
Generic Name
clobazam
Labeler
northstar rxllc
Dosage Form
SUSPENSION
Routes
Active Ingredients
clobazam 2.5 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
16714-087
Product ID
16714-087_f649cb16-8cb4-5292-e053-2995a90a04fc
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209796
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2020-05-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
16714087
Hyphenated Format
16714-087
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
clobazam (source: ndc)
Generic Name
clobazam (source: ndc)
Application Number
ANDA209796 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2.5 mg/mL
Packaging
- 1 BOTTLE, GLASS in 1 CARTON (16714-087-01) / 120 mL in 1 BOTTLE, GLASS
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f649cb16-8cb4-5292-e053-2995a90a04fc", "openfda": {"nui": ["N0000175694", "M0002356", "N0000182137", "N0000185506"], "upc": ["0316714087016"], "unii": ["2MRO291B4U"], "rxcui": ["1366192"], "spl_set_id": ["574a3f91-d73e-46bc-b4a1-2388439521fb"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_moa": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, GLASS in 1 CARTON (16714-087-01) / 120 mL in 1 BOTTLE, GLASS", "package_ndc": "16714-087-01", "marketing_start_date": "20200501"}], "brand_name": "Clobazam", "product_id": "16714-087_f649cb16-8cb4-5292-e053-2995a90a04fc", "dosage_form": "SUSPENSION", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "product_ndc": "16714-087", "dea_schedule": "CIV", "generic_name": "Clobazam", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clobazam", "active_ingredients": [{"name": "CLOBAZAM", "strength": "2.5 mg/mL"}], "application_number": "ANDA209796", "marketing_category": "ANDA", "marketing_start_date": "20200501", "listing_expiration_date": "20261231"}